Search

Elanco Animal Health Inc

Closed

SectorHealthcare

24.7 -2.76

Overview

Share price change

24h

Current

Min

24.35

Max

25.5

Key metrics

By Trading Economics

Income

289M

57M

Sales

227M

1.4B

P/E

Sector Avg

372.714

62.58

EPS

0.4

Profit margin

4.158

Employees

9,400

EBITDA

310M

316M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+18.94% upside

Dividends

By Acuity

Next Earnings

5 Aug 2026

Market Stats

By TradingEconomics

Market Cap

1.3B

13B

Previous open

27.46

Previous close

24.7

News Sentiment

By Acuity

34%

66%

76 / 340 Healthcare

Elanco Animal Health Inc Chart

Past performance is not a reliable indicator of future results.

Related News

22 Jul 2026, 19:25 UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21 Jul 2026, 19:26 UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20 Jul 2026, 19:46 UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Peer Comparison

Price change

Elanco Animal Health Inc Forecast

Price Target

By TipRanks

18.94% upside

12 Months Forecast

Average 30.14 USD  18.94%

High 32 USD

Low 26 USD

Based on 11 Wall Street analysts offering 12 month price targets forElanco Animal Health Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Sentiment

By Acuity

76 / 340 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
help-icon Live chat